Skip to content
Apogee Biotechnology Corporation

Apogee Biotechnology Corporation

  • Welcome
  • News
  • Technology
  • Lead Compound
  • Contact Us / Policies

Presentation on ABC294640 (opaganib) for Multiple Myeloma

Posted bylwm100 November 14, 2019May 20, 2020 Leave a comment on Presentation on ABC294640 (opaganib) for Multiple Myeloma

https://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=1384&PID=0&IID=10194

Posted bylwm100November 14, 2019May 20, 2020Posted inUncategorized

Post navigation

Previous Post Previous post:
Initiation of Phase IIa Study with ABC294640 (opaganib) for Cholangiocarcinoma at Mayo Clinic and MD Anderson
Next Post Next post:
Update on ABC294640 (opaganib)

Leave a comment

Cancel reply

Your email address will not be published. Required fields are marked *

Apogee Biotechnology Corporation, Proudly powered by WordPress.